Alx Oncology Holdings Inc’s recently made public that its CHIEF EXECUTIVE OFFICER Lettmann Jason acquired Company’s shares for reported $76892.0 on Sep 17 ’25. In the deal valued at $1.08 per share,71,163 shares were bought. As a result of this transaction, Lettmann Jason now holds 305,121 shares worth roughly $0.48 million.
Then, Lettmann Jason bought 21,070 shares, generating $22,461 in total proceeds. Upon buying the shares at $1.07, the CHIEF EXECUTIVE OFFICER now owns 233,958 shares.
Before that, Shantharam Harish bought 75,000 shares. Alx Oncology Holdings Inc shares valued at $58,402 were divested by the Chief Financial Officer at a price of $0.78 per share. As a result of the transaction, Shantharam Harish now holds 75,000 shares, worth roughly $0.12 million.
Jefferies initiated its Alx Oncology Holdings Inc [ALXO] rating to a Buy in a research note published on November 13, 2025; the price target was $4. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in early March from “a Hold” to “a Buy”. Jefferies also remained covering ALXO and has decreased its forecast on December 19, 2024 with a “Hold” recommendation from previously “Buy” rating. Stifel revised its rating on March 08, 2024. It rated ALXO as “a Hold” which previously was an “a Buy”.
Price Performance Review of ALXO
On Monday, Alx Oncology Holdings Inc [NASDAQ:ALXO] saw its stock jump 13.04% to $1.56. Over the last five days, the stock has gained 22.83%. Alx Oncology Holdings Inc shares have risen nearly 16.42% since the year began. Nevertheless, the stocks have fallen -6.59% over the past one year. While a 52-week high of $2.27 was reached on 10/06/25, a 52-week low of $0.40 was recorded on 06/27/25.
Levels Of Support And Resistance For ALXO Stock
The 24-hour chart illustrates a support level at 1.3967, which if violated will result in even more drops to 1.2333. On the upside, there is a resistance level at 1.6867. A further resistance level may holdings at 1.8133.
How much short interest is there in Alx Oncology Holdings Inc?
A steep rise in short interest was recorded in Alx Oncology Holdings Inc stocks on 2025-10-31, growing by 0.5 million shares to a total of 1.84 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 1.34 million shares. There was a rise of 27.3%, which implies that there is a positive sentiment for the stock.
